Bimzelx 160 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FCZZL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,137
Award facts
- Contract value 100% obligated
- $19,137.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,137.01 to AmerisourceBergen Drug Corp for BIMZELX 160 MG/ML Autoinjector on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. BIMZELX (bimekizumab) is a monoclonal antibody used in the treatment of moderate-to-severe plaque psoriasis and other inflammatory conditions, supplied in autoinjector format for patient administration.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 pharmaceutical prime vendor contract extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a wide range of medications and medical devices to support military and veteran healthcare systems. The SPE2DX contract serves as a global pharmaceutical support vehicle enabling the company to fulfill medical supply needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FCZZL?
SPE2DB25FCZZL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FCZZL worth?
The government has obligated $19,137 on SPE2DB25FCZZL.
Is contract SPE2DB25FCZZL an order under another contract?
Yes. SPE2DB25FCZZL is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FCZZL competed?
The extent of competition for SPE2DB25FCZZL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award